Tonsil or Adenoid Removal May Raise MS Activity in Kids

Credibility

Interest

Share:2 min read

Key Takeaway

Children who had their tonsils and/or adenoids removed had higher odds of developing MS and more relapses if they already had pediatric-onset MS.

What They Found

Researchers compared children with pediatric-onset MS to other children and found those who had adenotonsillectomy (surgery to remove tonsils and/or adenoids) were more likely to have MS. The study showed a 63% higher chance of having MS for kids who had the surgery, after accounting for other factors. In children who already had pediatric MS, those with the surgery had about twice as many relapses each year compared with those who did not. The tonsils and adenoids are places where Epstein-Barr virus (EBV) can live; EBV is a virus that has been linked to MS risk, and removing these tissues might change how the immune system interacts with the virus. Overall, the study suggests a link between removing these tissues, the EBV reservoir, and changes in immune activity related to MS, but it does not prove the surgery directly causes MS.

Who Should Care and Why

People with pediatric-onset MS and their caregivers should care because this finding could affect decisions about childhood ear, nose, and throat surgeries. Parents deciding on tonsil or adenoid removal for a child should discuss these results with their healthcare provider, especially if there is a family history of MS or other immune problems. Doctors who treat children may use this information to weigh the risks and benefits more carefully, much like thinking twice before removing a key part of a plumbing system in a house. Caregivers can use this knowledge to ask targeted questions about infection history, EBV testing, and follow-up plans after surgery. While this study does not give immediate treatment changes, it suggests monitoring and discussion are important when surgery is being considered for children at risk for MS.

Important Considerations

This study shows an association, which means the surgery and MS risk happened together, but it does not prove the surgery caused MS. The research is based on medical histories and follow-up from selected clinics, so results might not apply exactly the same to every child or community. Other factors, like how much EBV exposure a child had or why the surgery was done, may also matter but were not fully settled in this study.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Progression Clinical Trials Specific Symptoms

Article Topics:

Pediatric-onset multiple sclerosisadenoidectomyannualized relapse raterisk factorstonsillectomy

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News